Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 1.2.1.48 - long-chain-aldehyde dehydrogenase and Organism(s) Homo sapiens and UniProt Accession P51648

for references in articles please use BRENDA:EC1.2.1.48
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments
The best substrate is dodecylaldehyde.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
UNIPROT: P51648
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Bacteria, Eukaryota
Synonyms
fatty aldehyde dehydrogenase, aldh3b2, aldh10, long-chain aldehyde dehydrogenase, aldh3b3, falddh, long-chain fatty aldehyde dehydrogenase, membrane-bound fatty aldehyde dehydrogenase, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
fatty aldehyde dehydrogenase
-
membrane-bound fatty aldehyde dehydrogenase
-
ALDH10
-
-
ALDH3A2
Aldh3b1
-
-
dehydrogenase, long-chain aliphatic aldehyde
-
-
-
-
fatty aldehyde dehydrogenase
-
-
fatty aldehyde:NAD+ oxidoreductase
-
-
-
-
long-chain aldehyde dehydrogenase
-
-
-
-
long-chain fatty aldehyde dehydrogenase
-
-
-
-
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
a long-chain aldehyde + NAD+ + H2O = a long-chain carboxylate + NADH + 2 H+
show the reaction diagram
the human enzyme FALDH shows a unique reaction mechanism that differs from other ALDHs, modelling giving an alternative model for the reaction mechanism of FALDH, overview. The first step involves the activation of the catalytic Cys241 by deprotonation and subsequent substrate binding. Once Cys241 is deprotonated, it performs a nucleophilic attack on the carbonyl carbon of the fatty aldehyde, which forms a thiohemiacetal. Asn112 supports the orientation of the polar head group by coordinating to the substrate oxygen and subsequently stabilizes a tetrahedral reaction intermediate. In a second step, the collapse of the primarily formed oxyanion then initiates a hydride transfer to the NAD cofactor in a pro-R manner. Subsequently, a water molecule is deprotonated by Glu207 or Glu331 and triggers a nucleophilic attack of the hydroxide anion on the carbonyl carbon. In a final step, a repeated collapse of the oxyanion forms the fatty acid product and releases the covalent bond to Cys241, which remains activated or can be potentially reactivated
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
redox reaction
-
-
-
-
oxidation
-
-
-
-
reduction
-
-
-
-
PATHWAY SOURCE
PATHWAYS
SYSTEMATIC NAME
IUBMB Comments
long-chain-aldehyde:NAD+ oxidoreductase
The best substrate is dodecylaldehyde.
CAS REGISTRY NUMBER
COMMENTARY hide
59298-89-4
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
a long-chain aldehyde + NAD+ + H2O
a long-chain carboxylate + NADH + 2 H+
show the reaction diagram
-
-
-
?
acetaldehyde + NAD+ + H2O
acetate + NADH + H+
show the reaction diagram
-
-
-
?
arachidic aldehyde + NAD+ + H2O
arachidic acid + NADH
show the reaction diagram
-
-
-
?
behenic aldehyde + NAD+ + H2O
behenic acid + NADH
show the reaction diagram
-
-
-
?
benzaldehyde + NAD+ + H2O
benzoate + NADH + H+
show the reaction diagram
-
-
-
?
cis,cis-9,12-octadecadienal + NAD+ + H2O
cis,cis-9,12-octadecadienoic acid + NADH
show the reaction diagram
cis-11-hexadecenal + NAD+ + H2O
cis-11-hexadecenoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
cis-9-hexadecenal + NAD+ + H2O
cis-9-hexadecenoic acid + NADH
show the reaction diagram
-
-
-
?
cis-9-octadecenal + NAD+ + H2O
cis-9-octadecenoic acid + NADH
show the reaction diagram
-
-
-
?
crotonaldehyde + NAD+ + H2O
crotonic acid + NADH
show the reaction diagram
-
-
-
?
decanal + NAD+ + H2O
decanoic acid + NADH
show the reaction diagram
-
-
-
?
decanal + NAD+ + H2O
decanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
dihydrophytal + NAD+ + H2O
(3R,S,7R,11R)-3,7,11,15-tetramethylhexadecanoic acid + NADH
show the reaction diagram
-
-
-
?
dodecanal + NAD+ + H2O
dodecanoic acid + NADH
show the reaction diagram
-
-
-
?
dodecanal + NAD+ + H2O
dodecanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
farnesal + NAD+ + H2O
farnesoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
glutaraldehyde + NAD+
glutaric acid + NADH
show the reaction diagram
-
-
-
?
heptanal + NAD+ + H2O
heptanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH
show the reaction diagram
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
hexanal + NAD+ + H2O
hexanoate + NADH + H+
show the reaction diagram
-
-
-
?
long-chain aldehyde + NAD+
?
show the reaction diagram
-
-
-
-
?
long-chain aldehyde + NAD+ + H2O
long-chain acid anion + NADH
show the reaction diagram
-
-
-
?
long-chain aldehyde + NAD+ + H2O
long-chain carboxylate + NADH
show the reaction diagram
-
-
-
-
?
octadecanal + NAD+ + H2O
octadecanoic acid + NADH
show the reaction diagram
-
-
-
?
octadecanal + NAD+ + H2O
octadecanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
octadecanal + NADP+
octadecanoic acid + NADPH + H+
show the reaction diagram
-
-
-
-
r
octanal + NAD+ + H2O
octanoic acid + NADH + H+
show the reaction diagram
pentadecanal + NAD+ + H2O
pentadecanoic acid + NADH
show the reaction diagram
-
-
-
?
phytenal + NAD+
phytenic acid + NADH
show the reaction diagram
propionaldehyde + NAD+ + H2O
propionic acid + NADH
show the reaction diagram
-
-
-
?
pyrenedecanal + NAD+ + H2O
pyrenedecanoic acid + NADH
show the reaction diagram
-
-
-
-
?
tetradecanal + NAD+ + H2O
tetradecanoic acid + NADH
show the reaction diagram
-
-
-
?
tetradecanal + NAD+ + H2O
tetradecanoic acid + NADH + H+
show the reaction diagram
-
-
-
-
?
tetraeicosanal + NAD+ + H2O
tetraeicosanoic acid + NADH
show the reaction diagram
-
-
-
?
trans-2-hexadecenal + NAD+ + H2O
trans-2-decenoic acid + NADH
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
a long-chain aldehyde + NAD+ + H2O
a long-chain carboxylate + NADH + 2 H+
show the reaction diagram
-
-
-
?
cis,cis-9,12-octadecadienal + NAD+ + H2O
cis,cis-9,12-octadecadienoic acid + NADH
show the reaction diagram
-
major substrate
-
-
?
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH
show the reaction diagram
-
high activity
-
-
?
long-chain aldehyde + NAD+
?
show the reaction diagram
-
-
-
-
?
long-chain aldehyde + NAD+ + H2O
long-chain carboxylate + NADH
show the reaction diagram
-
-
-
-
?
phytenal + NAD+
phytenic acid + NADH
show the reaction diagram
-
the enzyme is involved in the breakdown of phytol
-
-
?
trans-2-hexadecenal + NAD+ + H2O
trans-2-decenoic acid + NADH
show the reaction diagram
-
-
-
-
?
additional information
?
-
-
Sjögren-Larsson syndrom is an inherited neurocutaneous disease caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, an enzyme involved in lipid metabolism. A rich diversity of mutations and haplotype associations is demonstrated in Sjögren-Larsson syndrom
-
-
?
COFACTOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
NAD+
a series of ALDHs have been shown to bind NAD in a conformation that results in a pro-R-specific hydride transfer during catalysis. The hydride transfer in FALDH is clearly pro-R specific. Residue Glu331 interacts with the ribose-backbone of NAD and assists correct cofactor binding and orientation
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
alpha,p-dibromoacetophenone
-
0.03 mM causes 100% inhibition
Chloral hydrate
-
25 mM causes 29% inhibition
Disulfiram
-
0.065 mM causes 100% inhibition
iodoacetamide
-
10 mM causes 96% inhibition
iodoacetate
-
10 mM causes 92% inhibition
N-ethylmaleimide
-
2 mM causes 43% inhibition
p-chloromercuribenzoate
-
0.01 mM causes complete inhibition
p-hydroxyacetophenone
-
0.25 mM causes 46% inhibition
potassium cyanide
-
1 mM causes 33% inhibition
Zn2+
-
1 mM causes 47% inhibition
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0343
(11Z)-hexadec-11-enal
-
-
2.5
acetaldehyde
-
-
0.038
arachidic aldehyde
-
-
0.036
behenic aldehyde
-
-
1.44
benzaldehyde
-
-
0.006
cis,cis-9,12-octadecadienal
-
-
0.012
cis-9-hexadecenal
-
-
0.011
cis-9-octadecenal
-
-
0.8
crotonaldehyde
-
-
0.0038 - 0.023
decanal
0.006
dihydrophytal
-
-
0.0136 - 0.019
dodecanal
0.023
farnesal
-
-
1.7
Glutaraldehyde
-
-
0.0083 - 0.032
hexadecanal
0.05
hexanal
-
-
0.18 - 0.28
NAD+
8.7
NADP+
-
reference substrate octadecanal
0.02 - 0.021
octadecanal
0.032
octanal
-
-
0.028
Pentadecanal
-
-
1.3
propionaldehyde
-
-
0.0103 - 0.023
Tetradecanal
0.018
tetraeicosanal
-
-
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1.4
(11Z)-hexadec-11-enal
-
-
2.18
decanal
-
-
2.23
dodecanal
-
-
0.93
farnesal
-
-
0.95
hexadecanal
-
-
1.28
NAD+
-
-
1.52
octadecanal
-
-
0.86
Tetradecanal
-
-
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
33.3
-
-
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
9.8
-
in glycine buffer
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
UniProt
Manually annotated by BRENDA team
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
-
-
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
membrane-bound. Membrane interaction of FALDH via its C-terminal transmembrane membrane domain, detailed overview
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
evolution
FALDH belongs to the superfamily of ALDHs, which are homooligomeric enzymes characterized by the presence of a cofactor-binding domain, a catalytic domain and a bridging domain involved in oligomerization. The C-terminal gatekeeper feature is conserved across membrane-associated aldehyde dehydrogenases
malfunction
mutations in the gene coding for membrane-bound fatty aldehyde dehydrogenase (FALDH) lead to toxic accumulation of lipid species and development of the Sjoegren-Larsson Syndrome (SLS), a rare disorder characterized by skin defects and mental retardation. Impaired FALDH function alters the metabolic profiles of connected pathways, molecular mechanism of SLS-causing mutations, overview
malfunction
metabolism
-
the enzyme is not involved in the long-chain base metabolism
physiological function
-
the likely physiological function of ALDH3B1 is to oxidize lipid-derived aldehydes generated in the plasma membrane
additional information
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
AL3A2_HUMAN
485
1
54848
Swiss-Prot
-
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
54000
-
x * 54000, SDS-PAGE
55000
-
2 * 55000, SDS-PAGE
57000
-
x * 57000, SDS-PAGE
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
homodimer
human FALDH forms a symmetrical dimer. Each FALDH subunit in the asymmetric unit adopts the canonical aldehyde dehydrogenase fold, including an aminoterminal (N-terminal) cofactor-binding domain (residues 1-79 and 103-208), a catalytic domain (residues 209-419) and an oligomerization domain (residues 82-102 and 420-443) that connects the two subunits of the dimer, and the C-terminal residues 445-460 that form an alpha helix. The recombinant enzyme is truncated and lacks the predicted transmembrane alpha-helical region (residues 464-485) that is not included in the expression constructs, due to incompatibility with the protein production process
homodimer
-
2 * 55000, SDS-PAGE
additional information
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
palmitoylation
-
-
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
purified recombinant enzyme, X-ray diffraction structure determination and analysis at 2.1 A resolution, molecular replacement using the human class 3 aldehyde dehydrogenase ALDH3A1, PDB ID 3SZA as search model, and modelling
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
C241S
site-directed mutagenesis, inactive active-site mutant
E207Q
site-directed mutagenesis, inactive mutant
E331Q
site-directed mutagenesis, inactive mutant
N112A
site-directed mutagenesis, inactive mutant
Y113F
site-directed mutagenesis, the mutant activity is unaltered compared to wild-type
Y410F
site-directed mutagenesis, the mutant shows normal Vmax/KM levels against octanal and dodecanal and a somewhat reduced but still considerable catalytic capacity for hexadecanal
D245N
-
NAD+ cosubstrate binding is occuring but catalytic reduction is diminished
G185A
-
disruption of NAD+ binding/utilisation
G412R
-
disruption of interaction of side-chains with substrate
H411Y
-
disruption of the key abstraction of the hydroxyl hydrogen
Q445R
-
substitution in the recombinant protein
T184M
-
disruption of NAD+ binding/utilisation
T184R
-
disruption of NAD+ binding/utilisation
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
47
-
5 min, the purified enzyme retains only 13% of its original activity
52
-
5 min, 100% loss of activity
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-20°C, 25 mM potassium phosphate, pH 7.5, 5% glycerol, 0.2 mM NAD+, 3 months, retains more than 80% of its original activity
-
4°C, 25 mM potassium phosphate, pH 7.5, 5% glycerol, 0.2 mM NAD+, 1 month, retains 67% of its original activity
-
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
recombinant Strep-tagged enzyme from Escherichia coli by affinity chromatography and gel filtration
recombinant His6-FADH purified by anion exchange and metal-chelate chromatography, to 90-95% purity
-
using chromatography on columns consisting of omega-aminohexyl-agarose and 5'-AMP-Sepharose 4B
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
gene ALDH3A2, recombinant expression of Strep-tagged enzyme in Escherichia coli, the enzyme lacks the predicted transmembrane alpha-helical region (residues 464-485) that is not included in the expression constructs, due to incompatibility with the protein production process
expressed in FAA-K1A cells
-
recombinant His6-FADH expressed in Escherichia coli BL21(DE3)
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Kelson, T.L.; Secor McVoy, J.R.; Rizzo, W.B.
Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization
Biochim. Biophys. Acta
1335
99-110
1997
Homo sapiens
Manually annotated by BRENDA team
Carney, G.; Wei, S.; Rizzo, W.B.
Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2
Hum. Mutat.
24
186
2004
Homo sapiens
Manually annotated by BRENDA team
van den Brink, D.M.; van Miert, J.N.; Dacremont, G.; Rontani, J.F.; Jansen, G.A.; Wanders, R.J.
Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid
Mol. Genet. Metab.
82
33-37
2004
Homo sapiens
Manually annotated by BRENDA team
Rizzo, W.B.; Carney, G.
Sjoegren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2)
Hum. Mutat.
26
1-10
2005
Homo sapiens
Manually annotated by BRENDA team
Gloerich, J.; Ijlst, L.; Wanders, R.J.; Ferdinandusse, S.
Bezafibrate induces FALDH in human fibroblasts; implications for Sjoegren-Larsson syndrome
Mol. Genet. Metab.
89
111-115
2006
Homo sapiens
Manually annotated by BRENDA team
Rizzo, W.B.
Sjoegren-Larsson syndrome: Molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency
Mol. Genet. Metab.
90
1-9
2007
Homo sapiens
Manually annotated by BRENDA team
Lloyd, M.D.; Boardman, K.D.; Smith, A.; van den Brink, D.M.; Wanders, R.J.; Threadgill, M.D.
Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjoegren-Larsson syndrome
J. Enzyme Inhib. Med. Chem.
22
584-590
2007
Homo sapiens
Manually annotated by BRENDA team
Kitamura, T.; Naganuma, T.; Abe, K.; Nakahara, K.; Ohno, Y.; Kihara, A.
Substrate specificity, plasma membrane localization, and lipid modification of the aldehyde dehydrogenase ALDH3B1
Biochim. Biophys. Acta
1831
1395-1401
2013
Homo sapiens
Manually annotated by BRENDA team
Keller, M.; Watschinger, K.; Golderer, G.; Maglione, M.; Sarg, B.; Lindner, H.; Werner-Felmayer, G.; Terrinoni, A.; Wanders, R.; Werner, E.
Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal
J. Lipid Res.
51
1554-1559
2010
Homo sapiens, Mus musculus, Rattus norvegicus
Manually annotated by BRENDA team
Keller, M.A.; Zander, U.; Fuchs, J.E.; Kreutz, C.; Watschinger, K.; Mueller, T.; Golderer, G.; Liedl, K.R.; Ralser, M.; Kraeutler, B.; Werner, E.R.; Marquez, J.A.
A gatekeeper helix determines the substrate specificity of Sjoegren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase
Nat. Commun.
5
4439
2014
Homo sapiens (P51648), Homo sapiens
Manually annotated by BRENDA team